stella
beta
PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC — Stella
Recruiting
Back to HER2 Insertion Mutation Positive Advanced NSCLC trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Hunan Provincal Tumor Hospital, Changsha, Hunan
View full record on ClinicalTrials.gov